ENGLISH ABSTRACT
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

[miR-155-5p alleviates lipopolysaccharide-induced inflammatory damage of human SH-SY5Y neuroblastoma cells by down-regulating SOCS1].

Objective To explore the effects of microRNA-155-5p (miR-155-5p) on lipopolysaccharide (LPS)-induced neuroinflammatory damage of human SH-SY5Y neuroblastoma cells. Methods SH-SY5Y cells line was overexpressed miR-155-5p or transfected with negative control (miR-155-5p mimic group, mimic-NC group), down-expressed miR-155-5p or transfected with its negative control (miR-155-5p inhibitor group, inhibitor-NC group). The cells with successful transfection in the above groups were treated with LPS for 24 hours. The cells without SH-SY5Y cells transfection and those with LPS treatment were included into control group and LPS group, respectively. The activity of SH-SY5Y cells was detected by MTT assay. The apoptosis rate was detected by flow cytometry. The mRNA levels of tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β), interleukin 6 (IL-6) and interleukin 10 (IL-10), and expression of miR-155-5p were detected by reverse transcription PCR. The levels of cleaved caspase-3 (c-caspase-3), B-cell lymphoma/leukemia-2 (Bcl2), Bcl2-associated X protein (BAX), phosphorylated nuclear factor κB p65/nuclear factor κB p65 (p-NF-κB p65/NF-κB p65) and phosphorylated p38 mitogen-activated protein kinase/p38 mitogen-activated protein kinase (p-p38 MAPK/p38 MAPK) were detected by Western blot analysis. The expression of miR-155-5p in SH-SY5Y cells was regulated by miR-155-5p mimic and miR-155-5p inhibitor. The target relationship between miR-155-5p and suppressor of cytokine signaling 1(SOCS1) was predicted by bioinformatics, which was verified by luciferase assay. SH-SY5Y cells with down-regulation of both miR-155-5p and SOCS1 were constructed (miR-155-5p inhibitor/si-SOCS1 group). The cells activity, apoptosis, mRNA expressions of inflammatory cytokines, expression of SOCS1 protein, ratios of p-NF-κB p65/NF-κB p65 and p-p38 MAPK/p38 MAPK were detected by the above methods. Results Compared with control group, activity of SH-SY5Y cells, expression of Bcl2 protein, level of IL-10 mRNA and expression of SOCS1 protein decreased in LPS group while apoptosis rate, expressions of c-caspase-3 and BAX proteins, and levels of TNF-α, IL-1β and IL-6 mRNA were increased, along with the increased miR-155-5p level and ratios of p-NF-κB p65/NF-κB p65 and p-p38 MAPK/p38 MAPK. The activity of SH-SY5Y cells, expression of Bcl2 protein, level of IL-10 mRNA and expression of SOCS1 protein increased in miR-155-5p inhibitor group, compared with LPS group, whereas decreased miR-155-5p level, apoptosis rate, expressions of c-caspase-3 and BAX proteins, levels of TNF-α, IL-1β and IL-6 mRNA, and expressions of p-NF-κB p65/NF-κB p65 and p-p38 MAPK/p38 MAPK proteins were observed. Compared with LPS group, activity of SH-SY5Y cells, expression of Bcl2 protein, level of IL-10 mRNA and expression of SOCS1 protein were decreased in miR-155-5p mimic group, while miR-155-5p level, apoptosis rate, expressions of c-caspase-3 and BAX proteins, levels of TNF-α, IL-1β and IL-6 mRNA, and ratios of p-NF-κB p65/NF-κB p65 and p-p38 MAPK/p38 MAPK proteins were increased. Targeted relationship was identified between miR-155-5p and SOCS1. Compared with miR-155-5p inhibitor group, cells activity and level of IL-10 mRNA decreased in miR-155-5p inhibitor/si-SOCS1 group, while apoptosis rate, ratios of p-NF-κB p65/NF-κB p65 and p-p38 MAPK/p38 MAPK, and levels of TNF-α, IL-1β and IL-6 mRNA increased. Conclusion Inhibiting miR-155-5p can alleviate neuroinflammatory damage induced by LPS, which may be related to down-regulating SOCS1 level.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app